BridgeBio Pharma (NasdaqGS:BBIO) Update / Briefing Transcript

BridgeBio Pharma (NasdaqGS:BBIO) Update / Briefing October 29, 2025 08:00 AM ET Company ParticipantsAndrew Tsai - SVPAnanth Sridhar - COO of CardiorenalMary Scott - Senior Director of Clinical DevelopmentNeil Kumar - CEOScott Adler - Chief Medical OfficerMatt Outten - Chief Commercial OfficerConference Call ParticipantsMani Foroohar - Senior Research AnalystAnupam Rama - AnalystTyler Van Buren - Managing Director and Senior Biotech Equity Research AnalystCory Kasimov - Senior Managing Director and Biotech A ...